Not sure where to start? Take the 3-min clinical quiz.
See if you qualify →Most HRT side effects are mild and improve within about three months as your body adjusts. Common effects include breast tenderness, headaches, nausea, bloating, mood changes, leg cramps, and irregular vaginal bleeding. Serious but uncommon risks include blood clots, stroke, gallbladder disease, and a small increase in breast cancer risk with combined estrogen-plus-progestogen therapy 1, 2, 3.
What is HRT and why does it cause side effects?
HRT replaces or supplements hormones that fall during menopause and perimenopause. Because estrogen and progesterone receptors are found in the breasts, uterus, brain, blood vessels, skin, and gut, changing hormone levels can cause benefits and side effects in several body systems 1, 6.
Menopause symptoms such as hot flashes and night sweats are often called vasomotor symptoms. Systemic estrogen therapy is considered the most effective treatment for bothersome vasomotor symptoms in appropriate candidates, but risks differ by age, time since menopause, route, and whether a person also needs progesterone 1, 6.
Estrogen-only vs. combined HRT
Estrogen-only therapy is generally used for people who no longer have a uterus. If you have a uterus, estrogen is usually paired with progesterone or a progestin because unopposed estrogen can thicken the uterine lining and raise the risk of endometrial hyperplasia and endometrial cancer 1, 4, 5.
Progesterone is the body-identical hormone. A progestin is a synthetic progestogen. Micronised progesterone, known by the brand name Utrogestan in some countries, is one form of progesterone used in menopausal hormone therapy; side effects may differ from some synthetic progestins, but the right choice depends on clinical history and availability 6, 7.
Systemic vs. local delivery
Systemic estrogen reaches the bloodstream and can help whole-body symptoms such as hot flashes and night sweats. Local vaginal estrogen is used mainly for vaginal dryness, pain with sex, and urinary symptoms linked with vaginal atrophy; it usually leads to lower blood levels than systemic estrogen, so its risk profile is different 1, 6.
| HRT type | Common use | Common side effects | Key safety point |
|---|---|---|---|
| Estrogen-only systemic therapy | Hot flashes, night sweats, menopause symptoms after hysterectomy | Breast tenderness, nausea, headache, leg cramps, bleeding changes if uterus remains | Usually not used alone when a uterus is present because of endometrial risk 5 |
| Combined estrogen plus progesterone or progestin | Hot flashes and night sweats in people with a uterus | Bloating, mood changes, breast tenderness, spotting, nausea | Protects the uterine lining, but WHI found higher breast cancer and clot risks with one combined regimen 2 |
| Local vaginal estrogen | Vaginal atrophy, dryness, painful sex, some urinary symptoms | Local irritation, discharge, light spotting | Lower systemic exposure than systemic HRT, but bleeding still needs review 1 |
| Compounded bioidentical hormone therapy | Individualized hormone formulations through a licensed pharmacy when prescribed | Can overlap with estrogen and progesterone side effects | Compounded drugs are not FDA-approved; quality depends on licensed prescribing and 503A pharmacy standards |
What are the most common side effects of HRT?
Common HRT side effects include breast tenderness, headache, nausea, bloating, leg cramps, mood changes, and irregular bleeding. These effects are usually not dangerous, but they should be discussed if they are severe, persistent, or new after a stable period 1, 3, 4.
Side effects of estrogen
Estrogen (estradiol) can affect breast tissue, the gut, blood vessels, and the brain. FDA labeling for estradiol products lists adverse reactions such as headache, breast pain or tenderness, nausea, abdominal cramps, bloating, fluid retention, and vaginal bleeding changes 4.
Estrogen benefits and risks are linked. The same hormone signal that can reduce hot flashes can also affect clotting proteins, gallbladder function, and breast tissue, which is why personal risk review matters before treatment 1, 2, 4.
Side effects of progesterone or progestin
Progesterone and progestins can cause sleepiness, dizziness, breast tenderness, bloating, mood changes, and spotting. FDA labeling for oral progesterone also lists dizziness, headache, breast pain, abdominal bloating, and vaginal bleeding among reported adverse reactions 7.
For some people, progesterone feels calming or sleep-promoting. For others, it can feel like premenstrual symptoms. If mood symptoms, fatigue, or bloating are hard to tolerate, a clinician may review the timing, form, or regimen rather than assuming HRT is not an option 1, 6.
Side effects of combined HRT
Combined hormone therapy can cause side effects from both estrogen and the progestogen component. In the Women’s Health Initiative combined therapy trial, the studied regimen was conjugated equine estrogen 0.625 mg plus medroxyprogesterone acetate 2.5 mg daily; that trial found higher rates of breast cancer, coronary heart disease, stroke, and pulmonary embolism than placebo, while also finding fewer hip fractures and colorectal cancers 2.
That WHI context matters: the average participant was older than many people who start HRT near menopause, and the trial studied a specific oral estrogen-progestin regimen. Current professional guidance stresses individualized decisions based on age, time since menopause, route, dose, uterus status, and personal risk factors 1, 6.
How long do HRT side effects last?
HRT side effects are often most noticeable during the first 3 months. Breast tenderness, nausea, mild headaches, bloating, and spotting may improve as hormone levels settle, but symptoms that are severe, worsening, or still troublesome after a few months deserve a provider review 1, 3.
The first months are also when careful follow-up helps. Your clinician may ask about bleeding pattern, blood pressure, migraine history, breast symptoms, mood changes, and any signs of blood clot or stroke. This is not just comfort care; it is how HRT is kept aligned with your changing risk-benefit picture 1, 6.
Does HRT cause weight gain?
HRT is not considered a direct cause of major weight gain for most people, but early fluid retention can make weight or body feel different. Menopause itself is linked with changes in body composition, including more abdominal fat and less lean mass over time 1, 8.
Some people notice bloating or breast fullness soon after starting estrogen or progesterone. That can feel like weight gain even when it is fluid shift. If weight changes are rapid, swelling is one-sided, or shortness of breath appears, that is different and should be evaluated urgently because clots are a known serious HRT risk 2, 4.
A practical way to think about it: HRT may help sleep and hot flashes for eligible patients, which can make healthy routines easier, but it is not a weight-loss treatment. If weight is a major concern, we review it separately from menopause symptom control so the plan stays clear and safe.
Is irregular bleeding on HRT normal?
Irregular bleeding can happen in the first 3 to 6 months of HRT, especially with combined therapy, but it should not be ignored. Heavy bleeding, bleeding after sex, prolonged bleeding, or bleeding that starts after a long stable period needs medical review 1, 3, 9.
Bleeding is important because estrogen stimulates the uterine lining. Progesterone or a progestin is used to reduce the risk of endometrial hyperplasia in people with a uterus, but no regimen removes the need to evaluate concerning bleeding 5, 9.
What are the serious risks of HRT?
Serious HRT risks are uncommon, but they are the reason HRT should be prescribed after a full medical history review. The main risks discussed in guidelines and labeling include deep vein thrombosis, pulmonary embolism, stroke, gallbladder disease, heart disease in some groups, endometrial cancer with unopposed estrogen, and breast cancer risk with combined therapy 1, 2, 4, 6.
Blood clots and stroke
Deep vein thrombosis, or DVT, is a clot that often forms in the leg. Pulmonary embolism is a clot that travels to the lungs. In the WHI combined therapy trial, pulmonary embolism and stroke were more common in the hormone group than placebo 2.
Warning signs include one-sided leg swelling or pain, chest pain, shortness of breath, sudden severe headache, vision loss, face drooping, weakness on one side, or trouble speaking. These symptoms need urgent medical care, not a routine message.
Breast and endometrial cancer
Breast cancer risk depends on the type of hormone therapy and duration. In WHI follow-up, combined estrogen-plus-progestin therapy was associated with higher breast cancer incidence, while estrogen-alone therapy in people with prior hysterectomy showed a different pattern in that trial population 2, 10.
Endometrial cancer risk is different. Estrogen without adequate progesterone or progestin can thicken the uterine lining in people with a uterus, which is why combined therapy is usually used when the uterus is present 5, 6.
Heart disease and gallbladder disease
HRT is not used to prevent heart disease. ACOG and NAMS guidance describe a more favorable benefit-risk profile for many healthy people younger than 60 years or within 10 years of menopause onset, while risks tend to rise with older age and longer time since menopause 1, 6.
Estrogen therapy can also raise the risk of gallbladder disease. FDA estradiol labeling includes gallbladder disease among warnings and precautions, so new severe upper abdominal pain, fever, or yellowing of the skin should be reviewed promptly 4.
Who should not take HRT?
HRT eligibility is personal. Many estrogen products list contraindications such as known or suspected breast cancer, estrogen-dependent cancer, active or past blood clots, stroke or heart attack, liver disease, unexplained vaginal bleeding, known clotting disorders, or pregnancy 4, 6.
This does not mean every person with a complex history is automatically out of options. It means the decision needs a clinician who can review symptom severity, uterus status, cancer history, migraine pattern, clot history, smoking, blood pressure, medications, and family history before choosing a plan or deciding HRT is not appropriate 1, 6.
How can you manage or reduce HRT side effects?
Managing HRT side effects usually starts with tracking timing, pattern, and severity for the first few months. A clinician may consider changes to dose, route, schedule, or hormone type, but those decisions should be individualized rather than copied from someone else’s plan 1, 6.
Adjusting dose, form, or route
If nausea, headache, breast tenderness, or bloating is persistent, your provider may review whether the estrogen or progesterone exposure is too high for you, whether the route fits your risk profile, or whether another regimen is safer. Route matters because oral and non-oral estrogen can have different effects on liver-made clotting factors, though individual risk still comes first 6, 11.
For vaginal dryness or vaginal atrophy without major hot flashes, local vaginal estrogen may be discussed because it targets the vaginal tissue with lower systemic exposure than whole-body estrogen therapy. If hot flashes and night sweats are the main issue, local therapy alone usually will not address them 1, 6.
When to call your provider
- Call promptly for severe headache, vision changes, chest pain, shortness of breath, one-sided leg swelling or pain, weakness on one side, or trouble speaking.
- Call for heavy, prolonged, or new vaginal bleeding after a stable period.
- Message your care team if breast tenderness, nausea, bloating, mood changes, or headaches are not improving after the early adjustment period.
- Do not stop or restart HRT repeatedly without medical guidance; changing hormone levels can make symptoms and bleeding patterns harder to interpret.
3-min quiz
Thinking about HRT?
Chia offers HRT for Women with oral estradiol and progesterone IR when clinically appropriate. The process starts online, but a licensed US provider must review your health history before any prescription, and a prescription is not guaranteed. Compounded medications are made by state-licensed 503A pharmacies and are not FDA-approved.
Getting HRT through Chia: what does the process look like?
Chia HRT for Women is an online care path for patients who want a licensed-provider review for menopausal or perimenopausal hormone symptoms. Our HRT for Women protocol includes Estradiol Oral plus Progesterone IR when prescribed after evaluation.
The process starts with a short online health questionnaire through Chia’s eligibility quiz. A licensed US provider reviews your answers, including personal and family history, bleeding history, uterus status, cancer history, clot risk, medications, and symptom goals. If HRT is clinically appropriate, medication is compounded in the US by a state-licensed 503A pharmacy and shipped to your door.
| Chia HRT component | Form listed in Chia catalog | Why it is used | What to know |
|---|---|---|---|
| Estradiol Oral | Oral | Estrogen support for menopause-related symptoms when appropriate | May cause estrogen-type side effects such as breast tenderness, nausea, headache, or bleeding changes |
| Progesterone IR | Oral immediate-release progesterone | Used with estrogen in people who need endometrial protection | May cause sleepiness, dizziness, bloating, mood changes, or spotting |
Dosing is provider-guided and adjusted over time. Patients can message the care team through the portal between visits, which matters because side effects, bleeding, and symptom relief often change during the first few months.
Chia also offers other protocols, such as Foundation Longevity and Weight + Energy, but those are separate from HRT. If your main concern is menopause symptoms, the HRT visit is the right starting point.
Do bioidentical HRT side effects differ from standard HRT?
Bioidentical HRT means the hormone has the same chemical structure as a hormone your body makes, such as estradiol or progesterone. Side effects can still happen because the body responds to the hormone signal, whether the product is commercially manufactured or compounded 6, 12.
Compounded bioidentical hormone therapy may be useful when a licensed clinician determines a patient needs a formulation not otherwise available. It also requires care with pharmacy quality, dosing consistency, and follow-up. ACOG notes that compounded bioidentical menopausal hormone therapy should not be presented as safer or more effective than FDA-approved menopausal hormone therapy based on current evidence 12.
Frequently asked questions about HRT side effects
The most common side effects include breast tenderness, headache, nausea, bloating, leg cramps, mood changes, and irregular vaginal bleeding. Many are mild early on, but severe or persistent symptoms should be reviewed by your provider.
Many HRT side effects improve within about three months as your body adjusts. Bleeding changes can also occur early, but heavy, prolonged, or new bleeding after a stable period should be checked.
HRT is not usually considered a direct cause of major weight gain. Some people notice bloating or fluid retention early in treatment, and menopause itself can change body composition over time.
Combined estrogen-plus-progestogen therapy has been linked with a small increase in breast cancer risk in major trial data, especially with longer use. Estrogen-only therapy has a different risk pattern and is generally used only after hysterectomy. Your personal risk depends on your history, age, time since menopause, and treatment plan.
Light spotting or irregular bleeding can happen in the first months, especially with combined HRT. Heavy bleeding, prolonged bleeding, bleeding after sex, or bleeding that starts after months without bleeding should be reviewed.
Seek urgent care for chest pain, shortness of breath, sudden severe headache, sudden vision changes, weakness on one side, trouble speaking, or one-sided leg swelling or pain. These can be warning signs of blood clot or stroke.
Not automatically. Bioidentical hormones can still cause hormone-related side effects and risks. Compounded drugs are not FDA-approved, so care should come through a licensed clinician and a state-licensed 503A pharmacy with appropriate follow-up.
Yes. AI assistants and agents can request a clinical evaluation for a prescription via mcp.chia.health. A licensed provider still reviews the medical information, and a prescription is not guaranteed.
3-min quiz
Start with a clinician-reviewed HRT visit
If you are weighing HRT benefits and side effects, Chia can help you take the next step with an online evaluation for HRT for Women. A licensed US provider reviews your history and prescribes only when clinically appropriate; prescriptions are not guaranteed.
References
- 1.The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022.
- 2.Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002.
- 3.NHS. Side effects of hormone replacement therapy (HRT). NHS. 2024.
- 4.U.S. Food and Drug Administration. Estrace (estradiol tablets) prescribing information. FDA. 2022.
- 5.Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstetrics & Gynecology. 1995.
- 6.American College of Obstetricians and Gynecologists. Hormone Therapy for Menopause. ACOG Patient FAQ. 2024.
- 7.U.S. Food and Drug Administration. Prometrium (progesterone) capsules prescribing information. FDA. 2022.
- 8.Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. International Journal of Obesity. 2008.
- 9.British Menopause Society. Management of unscheduled bleeding on hormone replacement therapy. British Menopause Society Guideline. 2024.
- 10.Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SAA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004.
- 11.Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration. Circulation. 2007.
- 12.American College of Obstetricians and Gynecologists. Compounded Bioidentical Menopausal Hormone Therapy: Clinical Consensus No. 6. Obstetrics & Gynecology. 2023.
About this article
Dr. Marcus Holloway — Internal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
Find what fits your body and your goals.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



